[126] Serious harms with long-term PPI use in older adults
Proton pump inhibitors (PPIs) were introduced in 1988. Health Canada, professional, and academic groups all agree that they should be prescribed at the lowest dose and for the shortest duration appropriate to the condition treated. However, PPI use continues to expand. Between 2000 and 2018 BC’s population grew by 20%, but use of PPIs increased by 257%. In 2018, 442,559 British Columbians (9% of … [Read more...]
[125] Can prescribers avoid contributing to opioid use disorder?
Case vignette: A 21 y/o has surgery for a condition expected to improve. He fills a discharge prescription for 5 days of an opioid at a standard dose. At 1-week follow-up with his family doctor for suture removal, he describes ongoing pain. Is a renewal of opioid appropriate, potentially dangerous, or both? Aggressive promotion of opioids for chronic non-cancer pain (CNCP) began in the … [Read more...]
Hitting the target but missing the point: The case against LDL and A1C targets
Dr. Aaron Tejani, PharmD gave this presentation on October 5th, 2019 in Vancouver, BC at the "Bringing Best Evidence to Clinicians" medical education conference marking the 25th anniversary of the UBC Therapeutics Initiative. Dr. Tejani is a clinical assistant professor with the Faculty of Pharmaceutical Sciences (University of British Columbia), Medication use evaluation pharmacist with Lower … [Read more...]
[Special Edition: March 2020] Pill splitting: Making the most of meds in a time of need
Français | Español | Português | 繁體中文 | 简体中文| عربي Clinical vignette A 54 year-old mechanic with type 2 diabetes and hypertension had a myocardial infarction in 2015. He currently takes ASA 81mg/d (over the counter) plus 6 generic prescription drugs dispensed monthly: atorvastatin 40mg/d ramipril 5mg/d empagliflozin 25mg/d escitalopram 10mg/d sildenafil 50mg 4 … [Read more...]
Rapid monitoring of health services utilization following a shift in coverage from brand name to biosimilar drugs in British Columbia—An interim report
Pharmacoepidemiol Drug Saf. 2020;1–8. First published: 28 May 2020. Fisher A, Kim JD, Dormuth CR Purpose: We explored changes in health services utilization associated with the Biosimilars Initiative introduced in British Columbia on May 27, 2019. To maintain drug coverage, the policy requires users of originator infliximab or etanercept to transition to biosimilar versions. We present a … [Read more...]
[Jul 9] Meaningful Medication Assessments Webinar #3: Informed Consent, Shared Decision Making
The Therapeutics Initiative in collaboration with Northern Health presented the third webinar in our Meaningful Medication Assessments series. This webinar covered the topics of informed consent and shared decision making. WHEN: Thursday, July 9th, 2020 at 12:00-13:00 PDT PRESENTERS: Aaron Tejani and Sydney Saunders LEARNING OBJECTIVES: identify and apply tools related to shared … [Read more...]
[Jun 24] Methods Speaker Series: Visualizing public health data: strategies and tools
TI Methods Speaker Series The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health, UBC Point Grey Campus. During the COVID-19 pandemic, while physical distancing measures are in effect, the TI Methods Speaker Series … [Read more...]
[Jun 18] Meaningful Medication Assessments Webinar #2: Collaborating to identify and reduce polypharmacy
The topic of the second Meaningful Medication Assessments Webinar, organized by the Therapeutics Initiative in collaboration with the Northern Health Authority was: “Collaborating to identify and reduce polypharmacy” PRESENTERS: Rob Pammett, Sydney Saunders, Gloria Chu, Dr. Ian Schokking WHEN: Thursday, June 18th, 2020 at 12:00 noon Pacific Daylight Time (UTC/GMT -7hrs) CME CREDITS: … [Read more...]
[Jun 4] Meaningful Medication Assessments Webinar #1: De-prescribing “to taper or stop: that is the question”
The topic of the first Meaningful Medication Assessments Webinar, organized by the Therapeutics Initiative in collaboration with the Northern Health Authority was: De-prescribing “to taper or stop: that is the question” PRESENTERS: Dr.Tom Perry, MD & Dr. Aaron Tejani, PharmD WHEN: Thursday, June 4th, 2020 at 12:00 noon Pacific Daylight Time (UTC/GMT -7hrs) CME CREDITS: Certification is … [Read more...]
Acetaminophen vs. NSAIDs during COVID-19 pandemic
TREATING FEVER AND PAIN in the time of COVID-19 Many people are asking doctors for information about whether it is safe to use NSAID drugs now. Examples of this drug class include ibuprofen (generic, Advil, Motrin), naproxen (generic, Aleve), diclofenac (generic, Voltaren, Arthrotec), celecoxib (Celebrex), meloxicam (Mobicox) and many others. Feeling an increase in your body temperature can … [Read more...]
- 1
- 2
- 3
- …
- 28
- Next Page »
